Development and Validation of a High Throughput System for Discovery of Antigens for Autoantibody Detection

An assay employing a panel of tumor-associated antigens has been validated and is available commercially (EarlyCDT®-Lung) to aid the early detection of lung cancer by measurement of serum autoantibodies. The high throughput (HTP) strategy described herein was pursued to identify new antigens to add...

Descripción completa

Detalles Bibliográficos
Autores principales: Macdonald, Isabel K., Allen, Jared, Murray, Andrea, Parsy-Kowalska, Celine B., Healey, Graham F., Chapman, Caroline J., Sewell, Herbert F., Robertson, John F. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399887/
https://www.ncbi.nlm.nih.gov/pubmed/22815807
http://dx.doi.org/10.1371/journal.pone.0040759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399887/
https://www.ncbi.nlm.nih.gov/pubmed/22815807
http://dx.doi.org/10.1371/journal.pone.0040759

Ejemplares similares